The New Alzheimer’s Drug: What is Leqembi?

แชร์
ฝัง
  • เผยแพร่เมื่อ 22 ธ.ค. 2024

ความคิดเห็น • 14

  • @sarahdisandro9306
    @sarahdisandro9306 ปีที่แล้ว +4

    Such valuable information for people living with Alzheimer's disease and their families. Looking forward to future episodes!

  • @crem8me
    @crem8me 4 หลายเดือนก่อน

    I am in a study involving lecanemab based out of Summit Research in Portland Oregon. I am now doing subcutaneous every week at home after a year plus of infusions at Summit.

  • @celestinai5475
    @celestinai5475 11 หลายเดือนก่อน +1

    Nice getting these informations.

    • @BrightfocusOrg
      @BrightfocusOrg  11 หลายเดือนก่อน

      Thank you. We are glad that you found this episode helpful.

  • @PieterCoetzee-zl7ms
    @PieterCoetzee-zl7ms ปีที่แล้ว +1

    From South Africa

  • @alexlex5792
    @alexlex5792 ปีที่แล้ว +4

    Leqembi finally gives time for the ill ❤. Much hope 🎉

  • @rudylampas2279
    @rudylampas2279 9 หลายเดือนก่อน

    Lord thank you so much. We are no longer hopeless and helpless.

  • @patriciaroberts491
    @patriciaroberts491 ปีที่แล้ว

    Is there a possibility of a person getting in to receive this new drug & help in the researching this drug?

    • @BrightfocusOrg
      @BrightfocusOrg  ปีที่แล้ว

      Thank you for your question. Leqembi received full approval from the FDA on July 6, 2023. It is an antibody that works to clear the brain of an abnormal protein called amyloid, known to be one of the root causes of Alzheimer’s. It’s intended for people who have mild cognitive impairment or mild dementia and are shown to have amyloid present in their brains.
      Please talk to your healthcare provider if you have questions or concerns about Leqembi. For more information about Leqembi, please visit bit.ly/3reLPOn.

  • @vinitawadhwa2206
    @vinitawadhwa2206 ปีที่แล้ว

    My wife has been diagnosed with Lowe body dementia, will this medicine be help full pl advice , we r from India

    • @BrightfocusOrg
      @BrightfocusOrg  ปีที่แล้ว +1

      Thank you for your question! Leqembi received full approval from the U.S. Food and Drug Administration on July 6, 2023. It is an antibody that works to clear the brain of an abnormal protein called amyloid, known to be one of the root causes of Alzheimer’s. It’s intended for people who have mild cognitive impairment or mild dementia and are shown to have amyloid present in their brains. To learn more, please visit www.brightfocus.org/alzheimers/article/facts-about-leqembi-new-alzheimers-drug.

  • @petermorla3250
    @petermorla3250 ปีที่แล้ว

    Can lequimbi be put into a pill form?

    • @BrightfocusOrg
      @BrightfocusOrg  ปีที่แล้ว

      Leqembi is not available in pill form. Leqembi is given through IV infusion every two weeks. It is available at certain infusion centers across the U.S. Each infusion lasts about an hour. Leqembi is given through IV infusion so that it more easily gets to the brain.
      Please talk to your healthcare provider if you have questions or concerns about Leqembi. For more information about Leqembi, please visit bit.ly/3reLPOn.